aDepartment of Hypertension, Centre for Epidemiological Studies and Clinical Trials, Shanghai Key Laboratory of Hypertension, The Shanghai Institute of Hypertension, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China
bDivision of Cardiovascular Medicine, Department of Medicine, Jichi Medical University School of Medicine, Tochigi, Japan
cCardiovascular Division, Cheil General Hospital, Kwandong University College of Medicine, Seoul, South Korea
dDepartment of Medical Education, Taipei Veterans General Hospital
eDepartment of Medicine
fDepartment of Public Health, Cardiovascular Research Center, National Yang-Ming University, Taipei, Taiwan
Correspondence to Ji-Guang Wang, MD, PhD, Department of Hypertension, Centre for Epidemiological Studies and Clinical Trials, Shanghai Key Laboratory of Hypertension, The Shanghai Institute of Hypertension, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Ruijin 2nd Road 197, Shanghai 200025, China. Tel: +86 21 64370045x610911; fax: +86 21 64662193; e-mail: [email protected]
Abbreviations: CI, confidence interval; CV, cardiovascular; HCTZ, hydrochlorothiazide; HF, heart failure; HR, hazard ratio; MI, myocardial infarction; TIA, transient ischaemic attack
Received 24 June, 2016
Revised 12 March, 2017
Accepted 22 March, 2017